JP2003500407A - プリン誘導体、それらの製造方法及びそれらを含有する製薬組成物 - Google Patents
プリン誘導体、それらの製造方法及びそれらを含有する製薬組成物Info
- Publication number
- JP2003500407A JP2003500407A JP2000619799A JP2000619799A JP2003500407A JP 2003500407 A JP2003500407 A JP 2003500407A JP 2000619799 A JP2000619799 A JP 2000619799A JP 2000619799 A JP2000619799 A JP 2000619799A JP 2003500407 A JP2003500407 A JP 2003500407A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- compound
- cyclopentyl
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title description 3
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 235
- -1 -CH2-Heterocycle Chemical group 0.000 claims abstract description 230
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 159
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 123
- 150000003839 salts Chemical class 0.000 claims abstract description 72
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 66
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 50
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 47
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 43
- 125000003118 aryl group Chemical group 0.000 claims abstract description 40
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 20
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 20
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 19
- 239000001301 oxygen Substances 0.000 claims abstract description 18
- 239000001257 hydrogen Substances 0.000 claims abstract description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 12
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 150000002367 halogens Chemical class 0.000 claims abstract description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 222
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 195
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 156
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 148
- 238000000034 method Methods 0.000 claims description 98
- 239000000126 substance Substances 0.000 claims description 81
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 80
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 74
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 36
- 125000000524 functional group Chemical group 0.000 claims description 34
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 30
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 29
- 125000005843 halogen group Chemical group 0.000 claims description 27
- 229920006395 saturated elastomer Polymers 0.000 claims description 27
- 239000002253 acid Substances 0.000 claims description 25
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 22
- 125000006239 protecting group Chemical group 0.000 claims description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 18
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 18
- 150000007522 mineralic acids Chemical class 0.000 claims description 17
- 150000007524 organic acids Chemical class 0.000 claims description 17
- 150000007530 organic bases Chemical class 0.000 claims description 16
- 150000007529 inorganic bases Chemical class 0.000 claims description 15
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 15
- 125000004434 sulfur atom Chemical group 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 12
- ABADUMLIAZCWJD-UHFFFAOYSA-N 1,3-dioxole Chemical group C1OC=CO1 ABADUMLIAZCWJD-UHFFFAOYSA-N 0.000 claims description 11
- 125000004429 atom Chemical group 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 10
- 125000005958 tetrahydrothienyl group Chemical group 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 8
- 125000004076 pyridyl group Chemical group 0.000 claims description 8
- 125000003158 alcohol group Chemical group 0.000 claims description 7
- 150000003457 sulfones Chemical class 0.000 claims description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 6
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000004414 alkyl thio group Chemical group 0.000 claims description 6
- 230000006907 apoptotic process Effects 0.000 claims description 6
- 150000002148 esters Chemical group 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 125000004001 thioalkyl group Chemical group 0.000 claims description 6
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 5
- 208000024827 Alzheimer disease Diseases 0.000 claims description 5
- LKMOGYXCKJCDQJ-GJFNAKTISA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C#N)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C#N)c2ncn(C3CCCC3)c2n1 LKMOGYXCKJCDQJ-GJFNAKTISA-N 0.000 claims description 5
- ZPFSQNUOEIAPRQ-PVPJKCDMSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)N2CCOCC2)c2ncn(C3CCCC3)c2n1 ZPFSQNUOEIAPRQ-PVPJKCDMSA-N 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 5
- 208000030852 Parasitic disease Diseases 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 5
- 150000001299 aldehydes Chemical group 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 230000002555 anti-neurodegenerative effect Effects 0.000 claims description 5
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 238000005886 esterification reaction Methods 0.000 claims description 5
- 125000005842 heteroatom Chemical group 0.000 claims description 5
- PNDPNCSMYVPNAC-UFLMWKHXSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC=2C=CC(CC#N)=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC=2C=CC(CC#N)=CC=2)=C(N=CN2C3CCCC3)C2=N1 PNDPNCSMYVPNAC-UFLMWKHXSA-N 0.000 claims description 4
- BUHHHGALIRRTAH-KWQHRWRSSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2cc(Cl)cc(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2cc(Cl)cc(Cl)c2)c2ncn(C3CCCC3)c2n1 BUHHHGALIRRTAH-KWQHRWRSSA-N 0.000 claims description 4
- GQLASWZZHAIYKC-HEOZJBRKSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(N)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(N)cc2)c2ncn(C3CCCC3)c2n1 GQLASWZZHAIYKC-HEOZJBRKSA-N 0.000 claims description 4
- RRGVHNJIDBLSFG-GVVKCMBXSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 RRGVHNJIDBLSFG-GVVKCMBXSA-N 0.000 claims description 4
- 238000002512 chemotherapy Methods 0.000 claims description 4
- 238000006722 reduction reaction Methods 0.000 claims description 4
- 150000003462 sulfoxides Chemical class 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- CPHXLFKIUVVIOQ-UHFFFAOYSA-N 2-(trifluoromethoxy)benzaldehyde Chemical group FC(F)(F)OC1=CC=CC=C1C=O CPHXLFKIUVVIOQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 3
- SXRKTCAMDLZVNT-UHFFFAOYSA-N Cl.Cl.CCOC(=O)C1=CC=CC=C1 Chemical compound Cl.Cl.CCOC(=O)C1=CC=CC=C1 SXRKTCAMDLZVNT-UHFFFAOYSA-N 0.000 claims description 3
- 229940064734 aminobenzoate Drugs 0.000 claims description 3
- 239000003080 antimitotic agent Substances 0.000 claims description 3
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 125000002757 morpholinyl group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 150000002923 oximes Chemical group 0.000 claims description 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 3
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 3
- 125000001422 pyrrolinyl group Chemical group 0.000 claims description 3
- 238000007127 saponification reaction Methods 0.000 claims description 3
- HUIQHUYSZNNWPQ-XAASAEJFSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCCNc2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCCNc2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 HUIQHUYSZNNWPQ-XAASAEJFSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 210000005036 nerve Anatomy 0.000 claims description 2
- 125000002560 nitrile group Chemical group 0.000 claims description 2
- 150000002828 nitro derivatives Chemical class 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims 2
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 claims 1
- XKTYXVDYIKIYJP-UHFFFAOYSA-N 3h-dioxole Chemical group C1OOC=C1 XKTYXVDYIKIYJP-UHFFFAOYSA-N 0.000 claims 1
- 229920002807 Thiomer Polymers 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 125000004542 purin-6-yl group Chemical group N1=CN=C2N=CNC2=C1* 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 3
- 239000011593 sulfur Substances 0.000 abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 381
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 369
- 239000000047 product Substances 0.000 description 347
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 315
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 259
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 258
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 211
- 239000012429 reaction media Substances 0.000 description 207
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 154
- 239000000377 silicon dioxide Substances 0.000 description 129
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 110
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 97
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 90
- 239000000243 solution Substances 0.000 description 85
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 79
- 239000002904 solvent Substances 0.000 description 77
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 76
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 75
- 239000000908 ammonium hydroxide Substances 0.000 description 75
- 239000013078 crystal Substances 0.000 description 75
- 239000003480 eluent Substances 0.000 description 75
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 description 70
- 238000004587 chromatography analysis Methods 0.000 description 65
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 60
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 57
- 230000008878 coupling Effects 0.000 description 48
- 238000010168 coupling process Methods 0.000 description 48
- 238000005859 coupling reaction Methods 0.000 description 48
- 238000000746 purification Methods 0.000 description 37
- 238000003756 stirring Methods 0.000 description 35
- 238000001704 evaporation Methods 0.000 description 33
- 239000011780 sodium chloride Substances 0.000 description 33
- 239000000463 material Substances 0.000 description 31
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 230000008020 evaporation Effects 0.000 description 27
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 22
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 20
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 18
- YMHQVDAATAEZLO-UHFFFAOYSA-N cyclohexane-1,1-diamine Chemical compound NC1(N)CCCCC1 YMHQVDAATAEZLO-UHFFFAOYSA-N 0.000 description 18
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 17
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 13
- 239000000460 chlorine Substances 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 12
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 9
- 229910000024 caesium carbonate Inorganic materials 0.000 description 9
- 238000006482 condensation reaction Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 229940093915 gynecological organic acid Drugs 0.000 description 8
- 235000005985 organic acids Nutrition 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- UDSRUCAJZSIRHZ-UHFFFAOYSA-N benzamide dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1.NC(=O)C1=CC=CC=C1 UDSRUCAJZSIRHZ-UHFFFAOYSA-N 0.000 description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- RMFWVOLULURGJI-UHFFFAOYSA-N 2,6-dichloro-7h-purine Chemical compound ClC1=NC(Cl)=C2NC=NC2=N1 RMFWVOLULURGJI-UHFFFAOYSA-N 0.000 description 5
- 239000005711 Benzoic acid Substances 0.000 description 5
- 235000010233 benzoic acid Nutrition 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000002329 infrared spectrum Methods 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 238000009938 salting Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 4
- XUJFOSLZQITUOI-UHFFFAOYSA-N 4-(trifluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)(F)F)C=C1 XUJFOSLZQITUOI-UHFFFAOYSA-N 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- KLQNJBAFEFFWQZ-UHFFFAOYSA-N benzoic acid;dihydrochloride Chemical compound Cl.Cl.OC(=O)C1=CC=CC=C1 KLQNJBAFEFFWQZ-UHFFFAOYSA-N 0.000 description 4
- 230000022131 cell cycle Effects 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- 229940098779 methanesulfonic acid Drugs 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- AQBJGAUQEJFPKZ-UHFFFAOYSA-N methyl 4-(aminomethyl)benzoate Chemical compound COC(=O)C1=CC=C(CN)C=C1 AQBJGAUQEJFPKZ-UHFFFAOYSA-N 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 239000011975 tartaric acid Substances 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- LQLOGZQVKUNBRX-UHFFFAOYSA-N (3-iodophenyl)methanamine Chemical compound NCC1=CC=CC(I)=C1 LQLOGZQVKUNBRX-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- XDPCNPCKDGQBAN-UHFFFAOYSA-N 3-hydroxytetrahydrofuran Chemical compound OC1CCOC1 XDPCNPCKDGQBAN-UHFFFAOYSA-N 0.000 description 3
- IMLXLGZJLAOKJN-UHFFFAOYSA-N 4-aminocyclohexan-1-ol Chemical compound NC1CCC(O)CC1 IMLXLGZJLAOKJN-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 3
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 3
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 150000002576 ketones Chemical group 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 229940095102 methyl benzoate Drugs 0.000 description 3
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 3
- 150000004965 peroxy acids Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 150000003212 purines Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- OPHQOIGEOHXOGX-UHFFFAOYSA-N 3,4,5-trimethoxybenzaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1OC OPHQOIGEOHXOGX-UHFFFAOYSA-N 0.000 description 2
- GSCPDZHWVNUUFI-UHFFFAOYSA-N 3-aminobenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1 GSCPDZHWVNUUFI-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- MUBJNMWVQGHHLG-UHFFFAOYSA-N 3-bromobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(Br)=C1 MUBJNMWVQGHHLG-UHFFFAOYSA-N 0.000 description 2
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 description 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 2
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 2
- DTJVECUKADWGMO-UHFFFAOYSA-N 4-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1 DTJVECUKADWGMO-UHFFFAOYSA-N 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- JDMWDOQSDQLVDU-IYARVYRRSA-N CCC(CC)n1cnc2c(NCc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound CCC(CC)n1cnc2c(NCc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 JDMWDOQSDQLVDU-IYARVYRRSA-N 0.000 description 2
- ASBNNQWOACRPDB-HDJSIYSDSA-N CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(CC)CC Chemical compound CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(CC)CC ASBNNQWOACRPDB-HDJSIYSDSA-N 0.000 description 2
- XRNLECHJVOZQTE-QSPIWVMWSA-N CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCOC1 Chemical compound CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCOC1 XRNLECHJVOZQTE-QSPIWVMWSA-N 0.000 description 2
- 101150012716 CDK1 gene Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LSVAYZPIKPRJJO-VAJGKAQFSA-N Cl.Cl.C1=CC(C)=CC=C1S(=O)(=O)NC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 Chemical compound Cl.Cl.C1=CC(C)=CC=C1S(=O)(=O)NC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 LSVAYZPIKPRJJO-VAJGKAQFSA-N 0.000 description 2
- KQYFSUFZFOLNMV-PMXFUEHMSA-N Cl.Cl.C1=CC(OC)=CC=C1S(=O)(=O)NCCNC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 Chemical compound Cl.Cl.C1=CC(OC)=CC=C1S(=O)(=O)NCCNC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 KQYFSUFZFOLNMV-PMXFUEHMSA-N 0.000 description 2
- VFIDXOGZJSJHDL-VAJGKAQFSA-N Cl.Cl.C1=CC(OCC)=CC=C1S(=O)(=O)NC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 Chemical compound Cl.Cl.C1=CC(OCC)=CC=C1S(=O)(=O)NC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 VFIDXOGZJSJHDL-VAJGKAQFSA-N 0.000 description 2
- CQXOKCPIVPZIRW-PMXFUEHMSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NCCNS(=O)(=O)C=2C=CC(Cl)=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NCCNS(=O)(=O)C=2C=CC(Cl)=CC=2)=C(N=CN2C3CCCC3)C2=N1 CQXOKCPIVPZIRW-PMXFUEHMSA-N 0.000 description 2
- RKNLYZUMBQHPRM-HLDGVKIBSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=C(Br)C=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=C(Br)C=CC=2)=C(N=CN2C3CCCC3)C2=N1 RKNLYZUMBQHPRM-HLDGVKIBSA-N 0.000 description 2
- WCBPSHAKOUUJIJ-HLDGVKIBSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC(Br)=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC(Br)=CC=2)=C(N=CN2C3CCCC3)C2=N1 WCBPSHAKOUUJIJ-HLDGVKIBSA-N 0.000 description 2
- DKVAQXJLUDXGLP-PYRPBJLNSA-N Cl.Cl.CCC(C)n1cnc2c(NCc3cccc(I)c3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(C)n1cnc2c(NCc3cccc(I)c3)nc(N[C@H]3CC[C@H](N)CC3)nc12 DKVAQXJLUDXGLP-PYRPBJLNSA-N 0.000 description 2
- OQIZZFMGBQPEJN-RSNMGLNFSA-N Cl.Cl.CCC(C)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(C)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 OQIZZFMGBQPEJN-RSNMGLNFSA-N 0.000 description 2
- ZKFJYQORWMHIRW-ADRWEOJYSA-N Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(C)CC Chemical compound Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C(C)CC ZKFJYQORWMHIRW-ADRWEOJYSA-N 0.000 description 2
- QIYVTOZIZUNLHQ-BJFPXTTKSA-N Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCSC1 Chemical compound Cl.Cl.CCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCSC1 QIYVTOZIZUNLHQ-BJFPXTTKSA-N 0.000 description 2
- MVUZCWTVSIZEOZ-HEWGHVJBSA-N Cl.Cl.COc1ccc(cc1)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound Cl.Cl.COc1ccc(cc1)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 MVUZCWTVSIZEOZ-HEWGHVJBSA-N 0.000 description 2
- CUVFFGLOHSQVSF-HEWGHVJBSA-N Cl.Cl.COc1ccc(cc1OC)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound Cl.Cl.COc1ccc(cc1OC)C(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 CUVFFGLOHSQVSF-HEWGHVJBSA-N 0.000 description 2
- WMRMUFYYYRTFAD-HEWGHVJBSA-N Cl.Cl.Cc1ccc(cc1)S(=O)(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound Cl.Cl.Cc1ccc(cc1)S(=O)(=O)NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 WMRMUFYYYRTFAD-HEWGHVJBSA-N 0.000 description 2
- QMMSPMBTLGVKJT-KWQHRWRSSA-N Cl.Cl.Cl.C1=CC(OC)=CC=C1CNCCNC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 Chemical compound Cl.Cl.Cl.C1=CC(OC)=CC=C1CNCCNC1=NC(N[C@@H]2CC[C@@H](N)CC2)=NC2=C1N=CN2C1CCCC1 QMMSPMBTLGVKJT-KWQHRWRSSA-N 0.000 description 2
- FTGRUVNHXIHMTG-KWQHRWRSSA-N Cl.Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NCCNCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NCCNCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 FTGRUVNHXIHMTG-KWQHRWRSSA-N 0.000 description 2
- QMDFRXFCDMVAIH-OESRCOROSA-N Cl.Cl.Cl.COc1cc(CNCCNc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc2OCOc12 Chemical compound Cl.Cl.Cl.COc1cc(CNCCNc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc2OCOc12 QMDFRXFCDMVAIH-OESRCOROSA-N 0.000 description 2
- FPYRELIZACSYJN-KWQHRWRSSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)cc2)c2ncn(C3CCCC3)c2n1 FPYRELIZACSYJN-KWQHRWRSSA-N 0.000 description 2
- OFGYPIALOQKIFW-OESRCOROSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCCC3)c2n1 OFGYPIALOQKIFW-OESRCOROSA-N 0.000 description 2
- PUAKDPZSARPWOT-HEWGHVJBSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(Cl)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(Cl)cc2)c2ncn(C3CCCC3)c2n1 PUAKDPZSARPWOT-HEWGHVJBSA-N 0.000 description 2
- OZIPQFMMTGRBDX-HLDGVKIBSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(cc2Cl)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(cc2Cl)[N+]([O-])=O)c2ncn(C3CCCC3)c2n1 OZIPQFMMTGRBDX-HLDGVKIBSA-N 0.000 description 2
- OHVIZTHZQNLWGK-WTQXULBFSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(I)c2)c2ncn(C3CCSC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(I)c2)c2ncn(C3CCSC3)c2n1 OHVIZTHZQNLWGK-WTQXULBFSA-N 0.000 description 2
- CTZQJPLXJFNKLY-WTQXULBFSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCOC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCOC3)c2n1 CTZQJPLXJFNKLY-WTQXULBFSA-N 0.000 description 2
- MOLMLTXMDRSTNY-WTQXULBFSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCSC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCSC3)c2n1 MOLMLTXMDRSTNY-WTQXULBFSA-N 0.000 description 2
- UYFCDGLZPZOCLG-AELULUIVSA-N Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCCC3)c2n1 UYFCDGLZPZOCLG-AELULUIVSA-N 0.000 description 2
- 101100059559 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) nimX gene Proteins 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000002927 anti-mitotic effect Effects 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- RMRMMALVBNUNHY-UHFFFAOYSA-N benzamide;trihydrochloride Chemical compound Cl.Cl.Cl.NC(=O)C1=CC=CC=C1 RMRMMALVBNUNHY-UHFFFAOYSA-N 0.000 description 2
- CUNTVNYKYKGHLP-UHFFFAOYSA-N benzenesulfonamide;dihydrochloride Chemical compound Cl.Cl.NS(=O)(=O)C1=CC=CC=C1 CUNTVNYKYKGHLP-UHFFFAOYSA-N 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 229940092714 benzenesulfonic acid Drugs 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical group C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- QYRFJLLXPINATB-UHFFFAOYSA-N hydron;2,4,5,6-tetrafluorobenzene-1,3-diamine;dichloride Chemical compound Cl.Cl.NC1=C(F)C(N)=C(F)C(F)=C1F QYRFJLLXPINATB-UHFFFAOYSA-N 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- RCBVKBFIWMOMHF-UHFFFAOYSA-L hydroxy-(hydroxy(dioxo)chromio)oxy-dioxochromium;pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1.O[Cr](=O)(=O)O[Cr](O)(=O)=O RCBVKBFIWMOMHF-UHFFFAOYSA-L 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- HUNUAFNLLYVTQD-UHFFFAOYSA-N methyl 2-chlorosulfonylbenzoate Chemical compound COC(=O)C1=CC=CC=C1S(Cl)(=O)=O HUNUAFNLLYVTQD-UHFFFAOYSA-N 0.000 description 2
- VZDNXXPBYLGWOS-UHFFFAOYSA-N methyl 3-aminobenzoate Chemical compound COC(=O)C1=CC=CC(N)=C1 VZDNXXPBYLGWOS-UHFFFAOYSA-N 0.000 description 2
- GIZCKBSSWNIUMZ-UHFFFAOYSA-N methyl 4-(aminomethyl)benzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=C(CN)C=C1 GIZCKBSSWNIUMZ-UHFFFAOYSA-N 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- PZKTZGCPNBRQGD-UHFFFAOYSA-N n-[2-[[2-[(4-aminocyclohexyl)amino]-9-cyclopentylpurin-6-yl]amino]ethyl]-3,4-dichlorobenzamide;dihydrochloride Chemical compound Cl.Cl.C1CC(N)CCC1NC1=NC(NCCNC(=O)C=2C=C(Cl)C(Cl)=CC=2)=C(N=CN2C3CCCC3)C2=N1 PZKTZGCPNBRQGD-UHFFFAOYSA-N 0.000 description 2
- FDVYDUFKGKTROA-UHFFFAOYSA-N n-[2-[[2-[(4-aminocyclohexyl)amino]-9-cyclopentylpurin-6-yl]amino]ethyl]-3,5-dichlorobenzamide;dihydrochloride Chemical compound Cl.Cl.C1CC(N)CCC1NC1=NC(NCCNC(=O)C=2C=C(Cl)C=C(Cl)C=2)=C(N=CN2C3CCCC3)C2=N1 FDVYDUFKGKTROA-UHFFFAOYSA-N 0.000 description 2
- OPTWHQOHFRXUEQ-UHFFFAOYSA-N n-[2-[[2-[(4-aminocyclohexyl)amino]-9-cyclopentylpurin-6-yl]amino]ethyl]-4-(trifluoromethyl)benzamide;dihydrochloride Chemical compound Cl.Cl.C1CC(N)CCC1NC1=NC(NCCNC(=O)C=2C=CC(=CC=2)C(F)(F)F)=C(N=CN2C3CCCC3)C2=N1 OPTWHQOHFRXUEQ-UHFFFAOYSA-N 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 150000002825 nitriles Chemical group 0.000 description 2
- GSWAOPJLTADLTN-UHFFFAOYSA-N oxidanimine Chemical compound [O-][NH3+] GSWAOPJLTADLTN-UHFFFAOYSA-N 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 125000005544 phthalimido group Chemical group 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- HERSKCAGZCXYMC-UHFFFAOYSA-N thiophen-3-ol Chemical compound OC=1C=CSC=1 HERSKCAGZCXYMC-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- IMLSAISZLJGWPP-UHFFFAOYSA-N 1,3-dithiolane Chemical compound C1CSCS1 IMLSAISZLJGWPP-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- PVBLJPCMWKGTOH-UHFFFAOYSA-N 1-aminocyclohexan-1-ol Chemical compound NC1(O)CCCCC1 PVBLJPCMWKGTOH-UHFFFAOYSA-N 0.000 description 1
- NHWXVMFKJPUCSX-UHFFFAOYSA-N 2,6-dichloro-9-(oxolan-3-yl)purine Chemical compound C12=NC(Cl)=NC(Cl)=C2N=CN1C1CCOC1 NHWXVMFKJPUCSX-UHFFFAOYSA-N 0.000 description 1
- CMYUXPKTNLTVJF-UHFFFAOYSA-N 2,6-dichloro-9-(thiolan-3-yl)purine Chemical compound C12=NC(Cl)=NC(Cl)=C2N=CN1C1CCSC1 CMYUXPKTNLTVJF-UHFFFAOYSA-N 0.000 description 1
- TVGDBGPLYZULGD-UHFFFAOYSA-N 2,6-dichloro-9-cyclopentylpurine Chemical compound C12=NC(Cl)=NC(Cl)=C2N=CN1C1CCCC1 TVGDBGPLYZULGD-UHFFFAOYSA-N 0.000 description 1
- GTQJBQLXSGFREX-UHFFFAOYSA-N 2,6-dichloro-9-pentan-3-ylpurine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1Cl GTQJBQLXSGFREX-UHFFFAOYSA-N 0.000 description 1
- YCWRFIYBUQBHJI-UHFFFAOYSA-N 2-(4-aminophenyl)acetonitrile Chemical compound NC1=CC=C(CC#N)C=C1 YCWRFIYBUQBHJI-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- JLRPFNVTZSQGQW-UHFFFAOYSA-N 2-[4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]phenyl]acetonitrile Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC1=CC=C(CC#N)C=C1 JLRPFNVTZSQGQW-UHFFFAOYSA-N 0.000 description 1
- AWFYPPSBLUWMFQ-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=C2 AWFYPPSBLUWMFQ-UHFFFAOYSA-N 0.000 description 1
- UPPDHRZSRWBXQJ-UHFFFAOYSA-N 2-amino-5-[[6-(benzylamino)-9-cyclopentylpurin-2-yl]amino]cyclohexan-1-ol;dihydrochloride Chemical compound Cl.Cl.C1C(O)C(N)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 UPPDHRZSRWBXQJ-UHFFFAOYSA-N 0.000 description 1
- AYUUKEMEFZPHQQ-UHFFFAOYSA-N 2-chloro-3-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=CC(C(Cl)=O)=C1Cl AYUUKEMEFZPHQQ-UHFFFAOYSA-N 0.000 description 1
- KTHNITVDTYAHFF-UHFFFAOYSA-N 2-chloro-4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C(Cl)=C1 KTHNITVDTYAHFF-UHFFFAOYSA-N 0.000 description 1
- LBXVRYDAWJLTPP-UHFFFAOYSA-N 2-chloro-9-(oxolan-3-yl)-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1COCC1 LBXVRYDAWJLTPP-UHFFFAOYSA-N 0.000 description 1
- JDSCHBFHVKTPOP-UHFFFAOYSA-N 2-chloro-9-(oxolan-3-yl)-n-propylpurin-6-amine Chemical compound C1=NC=2C(NCCC)=NC(Cl)=NC=2N1C1CCOC1 JDSCHBFHVKTPOP-UHFFFAOYSA-N 0.000 description 1
- DHLKWSBKYWTLTJ-UHFFFAOYSA-N 2-chloro-9-(thiolan-3-yl)-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CSCC1 DHLKWSBKYWTLTJ-UHFFFAOYSA-N 0.000 description 1
- VVCCZXKMOXYTNM-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-methoxyphenyl)purin-6-amine Chemical compound C1=CC(OC)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 VVCCZXKMOXYTNM-UHFFFAOYSA-N 0.000 description 1
- VMVVZWVDCTWZKO-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-morpholin-4-ylphenyl)purin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC(C=C1)=CC=C1N1CCOCC1 VMVVZWVDCTWZKO-UHFFFAOYSA-N 0.000 description 1
- PMBPCLILTMBHAS-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-nitrophenyl)purin-6-amine Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 PMBPCLILTMBHAS-UHFFFAOYSA-N 0.000 description 1
- OUJGOPWCEDFBIV-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-(4-phenylphenyl)purin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC(C=C1)=CC=C1C1=CC=CC=C1 OUJGOPWCEDFBIV-UHFFFAOYSA-N 0.000 description 1
- MWWYVVFQEVGYEZ-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-[4-(trifluoromethyl)phenyl]purin-6-amine Chemical compound C1=CC(C(F)(F)F)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 MWWYVVFQEVGYEZ-UHFFFAOYSA-N 0.000 description 1
- SOPSCIZOUSIZBH-UHFFFAOYSA-N 2-chloro-9-cyclopentyl-n-phenylpurin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC1=CC=CC=C1 SOPSCIZOUSIZBH-UHFFFAOYSA-N 0.000 description 1
- JQWHUCYPTGBVGV-UHFFFAOYSA-N 2-chloro-9-pentan-3-yl-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NC1=CC=C(OC(F)(F)F)C=C1 JQWHUCYPTGBVGV-UHFFFAOYSA-N 0.000 description 1
- ZKCUJEIFLJEGLQ-UHFFFAOYSA-N 2-chloro-9-pentan-3-yl-n-phenylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NC1=CC=CC=C1 ZKCUJEIFLJEGLQ-UHFFFAOYSA-N 0.000 description 1
- LYFDEZVSRMZHQE-UHFFFAOYSA-N 2-chloro-9-pentan-3-yl-n-propylpurin-6-amine Chemical compound CCCNC1=NC(Cl)=NC2=C1N=CN2C(CC)CC LYFDEZVSRMZHQE-UHFFFAOYSA-N 0.000 description 1
- DROWWEMDOGXVRX-UHFFFAOYSA-N 2-chloro-N-[(3-iodophenyl)methyl]-9-pentan-3-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NCC1=CC=CC(I)=C1 DROWWEMDOGXVRX-UHFFFAOYSA-N 0.000 description 1
- FSAXRNXWNOSEDP-UHFFFAOYSA-N 2-chloro-n-[(3-iodophenyl)methyl]-9-(oxolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3COCC3)C2=NC(Cl)=NC=1NCC1=CC=CC(I)=C1 FSAXRNXWNOSEDP-UHFFFAOYSA-N 0.000 description 1
- ZRGFSQMAXNGJFW-UHFFFAOYSA-N 2-chloro-n-[(3-iodophenyl)methyl]-9-(thiolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3CSCC3)C2=NC(Cl)=NC=1NCC1=CC=CC(I)=C1 ZRGFSQMAXNGJFW-UHFFFAOYSA-N 0.000 description 1
- JVCNVONHIMMTJU-UHFFFAOYSA-N 2-chloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-nitrobenzamide Chemical compound ClC1=CC([N+](=O)[O-])=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 JVCNVONHIMMTJU-UHFFFAOYSA-N 0.000 description 1
- OAPYKKWUOHTSFD-UHFFFAOYSA-N 2-chloro-n-phenyl-9-(thiolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3CSCC3)C2=NC(Cl)=NC=1NC1=CC=CC=C1 OAPYKKWUOHTSFD-UHFFFAOYSA-N 0.000 description 1
- KMVZDSQHLDGKGV-UHFFFAOYSA-N 2-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=CC=C1S(Cl)(=O)=O KMVZDSQHLDGKGV-UHFFFAOYSA-N 0.000 description 1
- ZSZKAQCISWFDCQ-UHFFFAOYSA-N 2-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=CC=C1S(Cl)(=O)=O ZSZKAQCISWFDCQ-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- RPPHLXGBYGEZAF-UHFFFAOYSA-N 3,4-dichloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzamide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNC(=O)C1=CC=C(Cl)C(Cl)=C1 RPPHLXGBYGEZAF-UHFFFAOYSA-N 0.000 description 1
- ZWUSBSHBFFPRNE-UHFFFAOYSA-N 3,4-dichlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1Cl ZWUSBSHBFFPRNE-UHFFFAOYSA-N 0.000 description 1
- VTXNOVCTHUBABW-UHFFFAOYSA-N 3,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C(Cl)=C1 VTXNOVCTHUBABW-UHFFFAOYSA-N 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- VIOBGCWEHLRBEP-UHFFFAOYSA-N 3,4-dimethoxybenzoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1OC VIOBGCWEHLRBEP-UHFFFAOYSA-N 0.000 description 1
- CASRSOJWLARCRX-UHFFFAOYSA-N 3,5-dichlorobenzaldehyde Chemical compound ClC1=CC(Cl)=CC(C=O)=C1 CASRSOJWLARCRX-UHFFFAOYSA-N 0.000 description 1
- GGHLXLVPNZMBQR-UHFFFAOYSA-N 3,5-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC(Cl)=CC(Cl)=C1 GGHLXLVPNZMBQR-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- ABFYEILPZWAIBN-UHFFFAOYSA-N 3-(iminomethylideneamino)-n,n-dimethylpropan-1-amine;hydrochloride Chemical compound Cl.CN(C)CCCN=C=N ABFYEILPZWAIBN-UHFFFAOYSA-N 0.000 description 1
- NZZZOYVRPOWZJQ-UHFFFAOYSA-N 3-(methylamino)benzamide Chemical group CNC1=CC=CC(C(N)=O)=C1 NZZZOYVRPOWZJQ-UHFFFAOYSA-N 0.000 description 1
- OKPFIWIMBJNFSE-UHFFFAOYSA-N 3-(trifluoromethoxy)benzoic acid Chemical compound OC(=O)C1=CC=CC(OC(F)(F)F)=C1 OKPFIWIMBJNFSE-UHFFFAOYSA-N 0.000 description 1
- ZUTVRDMZQSHCID-UHFFFAOYSA-N 3-(trifluoromethyl)benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 ZUTVRDMZQSHCID-UHFFFAOYSA-N 0.000 description 1
- IFMANFAYWLTAGD-UHFFFAOYSA-N 3-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzamide Chemical compound NC(=O)C1=CC=CC(NC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 IFMANFAYWLTAGD-UHFFFAOYSA-N 0.000 description 1
- TXYWFDDLFUNVOL-UHFFFAOYSA-N 3-chloro-n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]benzamide Chemical compound ClC1=CC=CC(C(=O)NCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 TXYWFDDLFUNVOL-UHFFFAOYSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- HEMYUAPEXJWFCP-UHFFFAOYSA-N 3-iodobenzamide Chemical compound NC(=O)C1=CC=CC(I)=C1 HEMYUAPEXJWFCP-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- FQXQBFUUVCDIRK-UHFFFAOYSA-N 3-trifluoromethylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(F)(F)F)=C1 FQXQBFUUVCDIRK-UHFFFAOYSA-N 0.000 description 1
- AROGTOONLWKAQP-UHFFFAOYSA-N 4-(fluoromethoxy)benzaldehyde Chemical compound FCOC1=CC=C(C=O)C=C1 AROGTOONLWKAQP-UHFFFAOYSA-N 0.000 description 1
- XQNVDQZWOBPLQZ-UHFFFAOYSA-N 4-(trifluoromethoxy)benzaldehyde Chemical compound FC(F)(F)OC1=CC=C(C=O)C=C1 XQNVDQZWOBPLQZ-UHFFFAOYSA-N 0.000 description 1
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 1
- OZDCZHDOIBUGAJ-UHFFFAOYSA-N 4-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=C(S(Cl)(=O)=O)C=C1 OZDCZHDOIBUGAJ-UHFFFAOYSA-N 0.000 description 1
- QIKYZXDTTPVVAC-UHFFFAOYSA-N 4-Aminobenzamide Chemical compound NC(=O)C1=CC=C(N)C=C1 QIKYZXDTTPVVAC-UHFFFAOYSA-N 0.000 description 1
- MUSGPBLMDJYJFX-UHFFFAOYSA-N 4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1NC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 MUSGPBLMDJYJFX-UHFFFAOYSA-N 0.000 description 1
- DAEZVLAETGNZDQ-UHFFFAOYSA-N 4-[(2-chloro-9-cyclopentylpurin-6-yl)amino]benzonitrile Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NC1=CC=C(C#N)C=C1 DAEZVLAETGNZDQ-UHFFFAOYSA-N 0.000 description 1
- WKDRXAYWMPQBAY-UHFFFAOYSA-N 4-[[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethylamino]methyl]benzonitrile Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNCC1=CC=C(C#N)C=C1 WKDRXAYWMPQBAY-UHFFFAOYSA-N 0.000 description 1
- GCTYHCFILCSUKE-UHFFFAOYSA-N 4-[[6-(benzylamino)-9-cyclopentylpurin-2-yl]amino]cyclohexan-1-one;dihydrochloride Chemical compound Cl.Cl.C1CC(=O)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 GCTYHCFILCSUKE-UHFFFAOYSA-N 0.000 description 1
- YBAZINRZQSAIAY-UHFFFAOYSA-N 4-aminobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1 YBAZINRZQSAIAY-UHFFFAOYSA-N 0.000 description 1
- STYQHICBPYRHQK-UHFFFAOYSA-N 4-bromobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(Br)C=C1 STYQHICBPYRHQK-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- ILKGEOVHANZEFC-UHFFFAOYSA-N 4-ethoxybenzenesulfonamide Chemical compound CCOC1=CC=C(S(N)(=O)=O)C=C1 ILKGEOVHANZEFC-UHFFFAOYSA-N 0.000 description 1
- CZKLEJHVLCMVQR-UHFFFAOYSA-N 4-fluorobenzoyl chloride Chemical compound FC1=CC=C(C(Cl)=O)C=C1 CZKLEJHVLCMVQR-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- PHNDZBFLOPIMSM-UHFFFAOYSA-N 4-morpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCOCC1 PHNDZBFLOPIMSM-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- WVOWEROKBOQYLJ-UHFFFAOYSA-N 4-propan-2-ylbenzenesulfonamide Chemical compound CC(C)C1=CC=C(S(N)(=O)=O)C=C1 WVOWEROKBOQYLJ-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KYDZEZNYRFJCSA-UHFFFAOYSA-N 4-tert-butylbenzenesulfonamide Chemical compound CC(C)(C)C1=CC=C(S(N)(=O)=O)C=C1 KYDZEZNYRFJCSA-UHFFFAOYSA-N 0.000 description 1
- ODGIMMLDVSWADK-UHFFFAOYSA-N 4-trifluoromethylaniline Chemical compound NC1=CC=C(C(F)(F)F)C=C1 ODGIMMLDVSWADK-UHFFFAOYSA-N 0.000 description 1
- JDLCNPVMTRZGHJ-UHFFFAOYSA-N 5-amino-2-[[6-(benzylamino)-9-cyclopentylpurin-2-yl]amino]cyclohexan-1-ol;dihydrochloride Chemical compound Cl.Cl.OC1CC(N)CCC1NC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 JDLCNPVMTRZGHJ-UHFFFAOYSA-N 0.000 description 1
- IJIBRSFAXRFPPN-UHFFFAOYSA-N 5-bromo-2-methoxybenzaldehyde Chemical compound COC1=CC=C(Br)C=C1C=O IJIBRSFAXRFPPN-UHFFFAOYSA-N 0.000 description 1
- LOFRBHZYZCIOJO-UHFFFAOYSA-N 7-methoxy-1,3-benzodioxole-5-carbaldehyde Chemical compound COC1=CC(C=O)=CC2=C1OCO2 LOFRBHZYZCIOJO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- NRDPEAYCIFBSSJ-UHFFFAOYSA-N 9-butan-2-yl-2,6-dichloropurine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1Cl NRDPEAYCIFBSSJ-UHFFFAOYSA-N 0.000 description 1
- ALVUQJMXAXUWGB-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-[4-(trifluoromethoxy)phenyl]purin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NC1=CC=C(OC(F)(F)F)C=C1 ALVUQJMXAXUWGB-UHFFFAOYSA-N 0.000 description 1
- SMEQPZPPGJZADL-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-phenylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NC1=CC=CC=C1 SMEQPZPPGJZADL-UHFFFAOYSA-N 0.000 description 1
- YSAVHHALZCIIOE-UHFFFAOYSA-N 9-butan-2-yl-2-chloro-n-propylpurin-6-amine Chemical compound CCCNC1=NC(Cl)=NC2=C1N=CN2C(C)CC YSAVHHALZCIIOE-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- ZXDSEXZJNXPFKA-JCNLHEQBSA-N CCC(CC)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound CCC(CC)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 ZXDSEXZJNXPFKA-JCNLHEQBSA-N 0.000 description 1
- JKZKKSWJRVPVET-UHFFFAOYSA-N CCC1=C(C(=C(C=C1CC(=O)O)CC(=O)O)CC)N Chemical compound CCC1=C(C(=C(C=C1CC(=O)O)CC(=O)O)CC)N JKZKKSWJRVPVET-UHFFFAOYSA-N 0.000 description 1
- 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 101150053721 Cdk5 gene Proteins 0.000 description 1
- JBAQOWJVYPUHNA-VAJGKAQFSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NC(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 JBAQOWJVYPUHNA-VAJGKAQFSA-N 0.000 description 1
- AOBDJTZQMUQRJA-HLDGVKIBSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1NC1=NC(NS(=O)(=O)C=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 AOBDJTZQMUQRJA-HLDGVKIBSA-N 0.000 description 1
- VZGGKNMFTAABFU-UFLMWKHXSA-N Cl.Cl.C1C[C@@H](N)CC[C@@H]1OC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 Chemical compound Cl.Cl.C1C[C@@H](N)CC[C@@H]1OC1=NC(NCC=2C=CC=CC=2)=C(N=CN2C3CCCC3)C2=N1 VZGGKNMFTAABFU-UFLMWKHXSA-N 0.000 description 1
- NAMFEHSNVMXGKU-ARKAGGOSSA-N Cl.Cl.CCC(C)n1cnc2c(Nc3ccc(OC(F)(F)F)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(C)n1cnc2c(Nc3ccc(OC(F)(F)F)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 NAMFEHSNVMXGKU-ARKAGGOSSA-N 0.000 description 1
- QZQSVPPMTLVZIJ-HEOZJBRKSA-N Cl.Cl.CCC(CC)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound Cl.Cl.CCC(CC)n1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 QZQSVPPMTLVZIJ-HEOZJBRKSA-N 0.000 description 1
- XXJUWWSURYTSCT-HEOZJBRKSA-N Cl.Cl.COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 Chemical compound Cl.Cl.COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3n(cnc23)C2CCCC2)cc1 XXJUWWSURYTSCT-HEOZJBRKSA-N 0.000 description 1
- NHRJSUXFBHVDJS-FGQYVNHASA-N Cl.Cl.Cl.NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 Chemical compound Cl.Cl.Cl.NCCNc1nc(N[C@H]2CC[C@H](N)CC2)nc2n(cnc12)C1CCCC1 NHRJSUXFBHVDJS-FGQYVNHASA-N 0.000 description 1
- HOOCMRPKWAJRDM-XNTUAKABSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(Cl)c2)c2ncn(C3CCCC3)c2n1 HOOCMRPKWAJRDM-XNTUAKABSA-N 0.000 description 1
- HYLVQTSWOSBCGP-XNTUAKABSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(c2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(Cl)c(c2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 HYLVQTSWOSBCGP-XNTUAKABSA-N 0.000 description 1
- NERAWQAXAJBKQM-KWQHRWRSSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(F)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(F)cc2)c2ncn(C3CCCC3)c2n1 NERAWQAXAJBKQM-KWQHRWRSSA-N 0.000 description 1
- KBMIYGDTPILQBN-KWQHRWRSSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 KBMIYGDTPILQBN-KWQHRWRSSA-N 0.000 description 1
- MGQFLKVQIQSSPP-KWQHRWRSSA-N Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2cccc(Cl)c2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNCc2cccc(Cl)c2)c2ncn(C3CCCC3)c2n1 MGQFLKVQIQSSPP-KWQHRWRSSA-N 0.000 description 1
- IVEHHBMSPMVSAC-UHFFFAOYSA-N Cl.Cl.NC1=NC(N)=C2NC=NC2=N1 Chemical compound Cl.Cl.NC1=NC(N)=C2NC=NC2=N1 IVEHHBMSPMVSAC-UHFFFAOYSA-N 0.000 description 1
- NJTWUMADPAQTHA-UHFFFAOYSA-N Cl.Cl.NS(=O)(=O)C(F)(F)F Chemical compound Cl.Cl.NS(=O)(=O)C(F)(F)F NJTWUMADPAQTHA-UHFFFAOYSA-N 0.000 description 1
- QZUODKRAAWEVIQ-HEWGHVJBSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(F)cc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(NCCNC(=O)c2ccc(F)cc2)c2ncn(C3CCCC3)c2n1 QZUODKRAAWEVIQ-HEWGHVJBSA-N 0.000 description 1
- DWBULZPGUPPLBY-ZWDMLWTRSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCSC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(OC(F)(F)F)cc2)c2ncn(C3CCSC3)c2n1 DWBULZPGUPPLBY-ZWDMLWTRSA-N 0.000 description 1
- YWNCUICVAWMHLW-SYPRRBKESA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)-c2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)-c2ccccc2)c2ncn(C3CCCC3)c2n1 YWNCUICVAWMHLW-SYPRRBKESA-N 0.000 description 1
- SXOJRQFOYBDWHC-HEOZJBRKSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)-c2nnn[nH]2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)-c2nnn[nH]2)c2ncn(C3CCCC3)c2n1 SXOJRQFOYBDWHC-HEOZJBRKSA-N 0.000 description 1
- QCXRKDDGPNLFIF-HEOZJBRKSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C(F)(F)F)c2ncn(C3CCCC3)c2n1 QCXRKDDGPNLFIF-HEOZJBRKSA-N 0.000 description 1
- GZNLVFMBXKFGFO-XVFXJROOSA-N Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCSC3)c2n1 Chemical compound Cl.Cl.N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccccc2)c2ncn(C3CCSC3)c2n1 GZNLVFMBXKFGFO-XVFXJROOSA-N 0.000 description 1
- FJEHRQUMJUVPHG-HPGRIBHPSA-N Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound Cl.O[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1 FJEHRQUMJUVPHG-HPGRIBHPSA-N 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical class CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- SGINLWOHMZPUEE-IYARVYRRSA-N N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(c2)C(O)=O)c2ncn(C3CCCC3)c2n1 Chemical compound N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(c2)C(O)=O)c2ncn(C3CCCC3)c2n1 SGINLWOHMZPUEE-IYARVYRRSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- HYDUFCBPSKFVRC-HQXWBSJKSA-N O[C@@H]([C@@H](O)C(O)=O)C(O)=O.CCC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 Chemical compound O[C@@H]([C@@H](O)C(O)=O)C(O)=O.CCC(C)n1cnc2c(NCc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc12 HYDUFCBPSKFVRC-HQXWBSJKSA-N 0.000 description 1
- YPAAHFFBWLYBHC-NIKMNUETSA-N O[C@@H]([C@@H](O)C(O)=O)C(O)=O.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(I)c2)c2ncn(C3CCOC3)c2n1 Chemical compound O[C@@H]([C@@H](O)C(O)=O)C(O)=O.N[C@H]1CC[C@@H](CC1)Nc1nc(NCc2cccc(I)c2)c2ncn(C3CCOC3)c2n1 YPAAHFFBWLYBHC-NIKMNUETSA-N 0.000 description 1
- BYIZPTGQONIDAW-UAPYVXQJSA-N O[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1 Chemical compound O[C@H]1CC[C@@H](CC1)Nc1nc(NCc2ccccc2)c2ncn(C3CCCC3)c2n1 BYIZPTGQONIDAW-UAPYVXQJSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 101100273808 Xenopus laevis cdk1-b gene Proteins 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical class C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- BIIVYFLTOXDAOV-YVEFUNNKSA-N alvocidib Chemical compound O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O BIIVYFLTOXDAOV-YVEFUNNKSA-N 0.000 description 1
- 229950010817 alvocidib Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- ASEYGLHOKYYOPX-UHFFFAOYSA-N benzamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1 ASEYGLHOKYYOPX-UHFFFAOYSA-N 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- BVQRJAUWOHUZNP-UHFFFAOYSA-N butyl benzoate dihydrochloride Chemical compound CCCCOC(=O)C1=CC=CC=C1.Cl.Cl BVQRJAUWOHUZNP-UHFFFAOYSA-N 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 101150059448 cdk7 gene Proteins 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002720 diazolyl group Chemical group 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- AWISGSJZNFRYNE-UHFFFAOYSA-N ethanol;dihydrochloride Chemical compound Cl.Cl.CCO AWISGSJZNFRYNE-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- CFNDVXUTYPXOPG-UHFFFAOYSA-N ethyl 2-(4-aminophenyl)acetate Chemical compound CCOC(=O)CC1=CC=C(N)C=C1 CFNDVXUTYPXOPG-UHFFFAOYSA-N 0.000 description 1
- KXSBWGSJFSEIED-UHFFFAOYSA-N ethyl 2-aminobutanoate Chemical compound CCOC(=O)C(N)CC KXSBWGSJFSEIED-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-L meso-tartrate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-XIXRPRMCSA-L 0.000 description 1
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- OPUAWDUYWRUIIL-UHFFFAOYSA-N methanedisulfonic acid Chemical compound OS(=O)(=O)CS(O)(=O)=O OPUAWDUYWRUIIL-UHFFFAOYSA-N 0.000 description 1
- 229940087646 methanolamine Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- FEIOASZZURHTHB-UHFFFAOYSA-N methyl 4-formylbenzoate Chemical compound COC(=O)C1=CC=C(C=O)C=C1 FEIOASZZURHTHB-UHFFFAOYSA-N 0.000 description 1
- ZFNYSVCLVLSNRF-UHFFFAOYSA-N methyl benzoate trihydrochloride Chemical compound Cl.Cl.Cl.COC(=O)C1=CC=CC=C1 ZFNYSVCLVLSNRF-UHFFFAOYSA-N 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- XSCIECAJYJCLQM-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-3-(trifluoromethyl)benzenesulfonohydrazide Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)NNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 XSCIECAJYJCLQM-UHFFFAOYSA-N 0.000 description 1
- ANLHKJJEYLJDKT-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-4-ethoxybenzenesulfonohydrazide Chemical compound C1=CC(OCC)=CC=C1S(=O)(=O)NNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 ANLHKJJEYLJDKT-UHFFFAOYSA-N 0.000 description 1
- VEHSPYSPEQBWTK-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-4-methylbenzenesulfonohydrazide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 VEHSPYSPEQBWTK-UHFFFAOYSA-N 0.000 description 1
- DWYCPFNJODGTTM-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3,4,5-trimethoxyphenyl)methyl]ethane-1,2-diamine Chemical compound COC1=C(OC)C(OC)=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 DWYCPFNJODGTTM-UHFFFAOYSA-N 0.000 description 1
- YZEJTLHDSIWFME-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3,4-dichlorophenyl)methyl]ethane-1,2-diamine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNCC1=CC=C(Cl)C(Cl)=C1 YZEJTLHDSIWFME-UHFFFAOYSA-N 0.000 description 1
- YGOORGQQYROFSM-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3,5-dichlorophenyl)methyl]ethane-1,2-diamine Chemical compound ClC1=CC(Cl)=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 YGOORGQQYROFSM-UHFFFAOYSA-N 0.000 description 1
- QNTZFOGPMMLQCX-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(3-chlorophenyl)methyl]ethane-1,2-diamine Chemical compound ClC1=CC=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 QNTZFOGPMMLQCX-UHFFFAOYSA-N 0.000 description 1
- RTXZWORQKAJOFL-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(4-chlorophenyl)methyl]ethane-1,2-diamine Chemical compound C1=CC(Cl)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 RTXZWORQKAJOFL-UHFFFAOYSA-N 0.000 description 1
- ZLOODNNWRVFGQY-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(4-fluorophenyl)methyl]ethane-1,2-diamine Chemical compound C1=CC(F)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 ZLOODNNWRVFGQY-UHFFFAOYSA-N 0.000 description 1
- KJYTXNRYGIATAA-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]ethane-1,2-diamine Chemical compound C=1C=2OCOC=2C(OC)=CC=1CNCCNC(C=1N=C2)=NC(Cl)=NC=1N2C1CCCC1 KJYTXNRYGIATAA-UHFFFAOYSA-N 0.000 description 1
- FGVGDJILZZBXQU-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[[4-(trifluoromethoxy)phenyl]methyl]ethane-1,2-diamine Chemical compound C1=CC(OC(F)(F)F)=CC=C1CNCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 FGVGDJILZZBXQU-UHFFFAOYSA-N 0.000 description 1
- XWOCAFOOAUIQKY-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)-n-[[4-chloro-3-(trifluoromethyl)phenyl]methyl]ethane-1,2-diamine Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(CNCCNC=2C=3N=CN(C=3N=C(Cl)N=2)C2CCCC2)=C1 XWOCAFOOAUIQKY-UHFFFAOYSA-N 0.000 description 1
- WFAKXKVHHXGZIJ-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)benzenesulfonohydrazide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NNS(=O)(=O)C1=CC=CC=C1 WFAKXKVHHXGZIJ-UHFFFAOYSA-N 0.000 description 1
- RHOAHBLVHCUZBB-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)ethane-1,2-diamine Chemical compound C1=NC=2C(NCCN)=NC(Cl)=NC=2N1C1CCCC1 RHOAHBLVHCUZBB-UHFFFAOYSA-N 0.000 description 1
- WEHQXUPZGVIXLS-UHFFFAOYSA-N n'-(2-chloro-9-cyclopentylpurin-6-yl)pyridine-3-sulfonohydrazide Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NNS(=O)(=O)C1=CC=CN=C1 WEHQXUPZGVIXLS-UHFFFAOYSA-N 0.000 description 1
- BFLKQFRFSGCWRN-UHFFFAOYSA-N n'-benzhydryl-n-(2-chloro-9-cyclopentylpurin-6-yl)ethane-1,2-diamine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNC(C=1C=CC=CC=1)C1=CC=CC=C1 BFLKQFRFSGCWRN-UHFFFAOYSA-N 0.000 description 1
- AKPBXEIYIYWEFI-UHFFFAOYSA-N n-(trifluoromethyl)benzenesulfonamide Chemical compound FC(F)(F)NS(=O)(=O)C1=CC=CC=C1 AKPBXEIYIYWEFI-UHFFFAOYSA-N 0.000 description 1
- SLDBXMFBOFIMAL-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-1,1,1-trifluoromethanesulfonamide Chemical compound C1=NC=2C(NCCNS(=O)(=O)C(F)(F)F)=NC(Cl)=NC=2N1C1CCCC1 SLDBXMFBOFIMAL-UHFFFAOYSA-N 0.000 description 1
- WPSNSOBUGDVDBA-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-3,4-dimethoxybenzamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 WPSNSOBUGDVDBA-UHFFFAOYSA-N 0.000 description 1
- GTVCBPDKPLBEMM-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-fluorobenzamide Chemical compound C1=CC(F)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 GTVCBPDKPLBEMM-UHFFFAOYSA-N 0.000 description 1
- GIAFFJATAKDHTN-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-fluorobenzenesulfonamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 GIAFFJATAKDHTN-UHFFFAOYSA-N 0.000 description 1
- JAFOXORPADOCKD-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 JAFOXORPADOCKD-UHFFFAOYSA-N 0.000 description 1
- IZQYPUHUYMUXSH-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCNC1=NC(Cl)=NC2=C1N=CN2C1CCCC1 IZQYPUHUYMUXSH-UHFFFAOYSA-N 0.000 description 1
- XFALHLCWYBNJOR-UHFFFAOYSA-N n-[2-[(2-chloro-9-cyclopentylpurin-6-yl)amino]ethyl]propane-2-sulfonamide Chemical compound C1=NC=2C(NCCNS(=O)(=O)C(C)C)=NC(Cl)=NC=2N1C1CCCC1 XFALHLCWYBNJOR-UHFFFAOYSA-N 0.000 description 1
- UDUOCRUXMANDCI-UHFFFAOYSA-N n-benzyl-2-chloro-9-(oxolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3COCC3)C2=NC(Cl)=NC=1NCC1=CC=CC=C1 UDUOCRUXMANDCI-UHFFFAOYSA-N 0.000 description 1
- PCEUCOTXPALORE-UHFFFAOYSA-N n-benzyl-2-chloro-9-(thiolan-3-yl)purin-6-amine Chemical compound C=12N=CN(C3CSCC3)C2=NC(Cl)=NC=1NCC1=CC=CC=C1 PCEUCOTXPALORE-UHFFFAOYSA-N 0.000 description 1
- APURIMWVMQIOPD-UHFFFAOYSA-N n-benzyl-2-chloro-9-cyclopentylpurin-6-amine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCC1=CC=CC=C1 APURIMWVMQIOPD-UHFFFAOYSA-N 0.000 description 1
- IVWAKBQIWKSQOL-UHFFFAOYSA-N n-benzyl-2-chloro-9-pentan-3-ylpurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(CC)CC)C=NC2=C1NCC1=CC=CC=C1 IVWAKBQIWKSQOL-UHFFFAOYSA-N 0.000 description 1
- HFRGFRFJCWEUJH-UHFFFAOYSA-N n-benzyl-9-butan-2-yl-2-chloropurin-6-amine Chemical compound N1=C(Cl)N=C2N(C(C)CC)C=NC2=C1NCC1=CC=CC=C1 HFRGFRFJCWEUJH-UHFFFAOYSA-N 0.000 description 1
- RMDSNTGPWAIXSF-UHFFFAOYSA-N n-benzyl-n'-(2-chloro-9-cyclopentylpurin-6-yl)ethane-1,2-diamine Chemical compound C=12N=CN(C3CCCC3)C2=NC(Cl)=NC=1NCCNCC1=CC=CC=C1 RMDSNTGPWAIXSF-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- GTVPOLSIJWJJNY-UHFFFAOYSA-N olomoucine Chemical compound N1=C(NCCO)N=C2N(C)C=NC2=C1NCC1=CC=CC=C1 GTVPOLSIJWJJNY-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- FTHGKDLUXAQKFS-UHFFFAOYSA-N oxolane-2-thiol Chemical compound SC1CCCO1 FTHGKDLUXAQKFS-UHFFFAOYSA-N 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- SEVSMVUOKAMPDO-UHFFFAOYSA-N para-Acetoxybenzaldehyde Natural products CC(=O)OC1=CC=C(C=O)C=C1 SEVSMVUOKAMPDO-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- RPGWZZNNEUHDAQ-UHFFFAOYSA-N phenylphosphine Chemical compound PC1=CC=CC=C1 RPGWZZNNEUHDAQ-UHFFFAOYSA-N 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- BBFCIBZLAVOLCF-UHFFFAOYSA-N pyridin-1-ium;bromide Chemical compound Br.C1=CC=NC=C1 BBFCIBZLAVOLCF-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- NKFLEFWUYAUDJV-UHFFFAOYSA-N pyridine-3-sulfonamide Chemical compound NS(=O)(=O)C1=CC=CN=C1 NKFLEFWUYAUDJV-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000005307 thiatriazolyl group Chemical group S1N=NN=C1* 0.000 description 1
- BJYXNFYVCZIXQC-UHFFFAOYSA-N thiolan-3-ol Chemical compound OC1CCSC1 BJYXNFYVCZIXQC-UHFFFAOYSA-N 0.000 description 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- ZMCBYSBVJIMENC-UHFFFAOYSA-N tricaine Chemical compound CCOC(=O)C1=CC=CC(N)=C1 ZMCBYSBVJIMENC-UHFFFAOYSA-N 0.000 description 1
- KAKQVSNHTBLJCH-UHFFFAOYSA-N trifluoromethanesulfonimidic acid Chemical compound NS(=O)(=O)C(F)(F)F KAKQVSNHTBLJCH-UHFFFAOYSA-N 0.000 description 1
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9906456A FR2793794B1 (fr) | 1999-05-21 | 1999-05-21 | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| FR99/06456 | 1999-05-21 | ||
| PCT/FR2000/001335 WO2000071543A1 (fr) | 1999-05-21 | 2000-05-18 | Derives de la purine, leur procede de preparation, et compositions pharmaceutiques les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003500407A true JP2003500407A (ja) | 2003-01-07 |
| JP2003500407A5 JP2003500407A5 (enExample) | 2007-07-05 |
Family
ID=9545846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000619799A Abandoned JP2003500407A (ja) | 1999-05-21 | 2000-05-18 | プリン誘導体、それらの製造方法及びそれらを含有する製薬組成物 |
Country Status (33)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006517955A (ja) * | 2003-02-18 | 2006-08-03 | アベンティス・ファーマ・ソシエテ・アノニム | 新規なプリン誘導体、それらの製造方法、医薬品としての適用、薬学的組成物、および新規な使用 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| US6969720B2 (en) | 1999-03-17 | 2005-11-29 | Amr Technology, Inc. | Biaryl substituted purine derivatives as potent antiproliferative agents |
| EP1377579B1 (en) * | 2000-10-31 | 2009-03-25 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| US6861524B2 (en) * | 2000-10-31 | 2005-03-01 | Aventis Pharmaceuticals Inc. | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
| US6812232B2 (en) | 2001-09-11 | 2004-11-02 | Amr Technology, Inc. | Heterocycle substituted purine derivatives as potent antiproliferative agents |
| US6667311B2 (en) * | 2001-09-11 | 2003-12-23 | Albany Molecular Research, Inc. | Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents |
| CA2463563A1 (en) * | 2001-10-12 | 2003-04-17 | Irm Llc | Kinase inhibitor scaffolds and methods for their preparation |
| AU2003301407B2 (en) * | 2002-10-15 | 2010-04-22 | Irm Llc | Compositions and methods for inducing osteogenesis |
| WO2005047524A2 (en) | 2003-11-10 | 2005-05-26 | The Scripps Research Institute | Compositions and methods for inducing cell dedifferentiation |
| AU2005231440B9 (en) * | 2004-04-02 | 2012-02-23 | Dogwood Pharmaceuticals, Inc. | Selective antagonists of A2A adenosine receptors |
| CZ302122B6 (cs) * | 2009-01-28 | 2010-10-20 | Univerzita Palackého v Olomouci | Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující |
| WO2012142029A2 (en) | 2011-04-10 | 2012-10-18 | Florida A&M University | Serms for the treatment of estrogen receptor-mediated disorders |
| WO2015162518A1 (en) | 2014-04-25 | 2015-10-29 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
| EP4086257A1 (en) * | 2016-09-30 | 2022-11-09 | SRI International | Dual clk/cdk1 inhibitors for cancer treatment |
| CZ308029B6 (cs) | 2017-03-20 | 2019-11-06 | Univerzita PalackĂ©ho v Olomouci | 2,6-Disubstituované-9-cyklopentyl-9H-puriny, jejich použití jako léčiva a farmaceutické přípravky |
| AR131380A1 (es) | 2022-12-16 | 2025-03-12 | Astrazeneca Ab | Purinas 2,6,9-trisustituidas |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4008858A1 (de) * | 1990-03-20 | 1991-09-26 | Hoechst Ag | Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel |
| EP0841810B1 (en) * | 1991-12-05 | 2000-06-21 | Texas Instruments Incorporated | Method to improve a video signal |
| CA2084222C (en) * | 1991-12-06 | 2004-04-06 | David R. Borcherding | Novel trans cyclopentanyl purine analogs useful as immunosuppressants |
| CN1066147C (zh) * | 1995-11-01 | 2001-05-23 | 诺瓦提斯公司 | 嘌呤衍生物及其制备方法 |
| FR2741881B1 (fr) * | 1995-12-01 | 1999-07-30 | Centre Nat Rech Scient | Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques |
| US6790958B2 (en) * | 1996-08-02 | 2004-09-14 | Robert T. Lum | Purine inhibitors of cyclin dependent kinase 2 & IKBA |
| US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
| WO1998016528A1 (en) * | 1996-10-11 | 1998-04-23 | Chiron Corporation | Purine inhibitors of glycogen synthase kinase 3 (gsk3) |
| WO1999007705A1 (en) * | 1997-08-07 | 1999-02-18 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
| US6413974B1 (en) * | 1998-02-26 | 2002-07-02 | Aventis Pharmaceuticals Inc. | 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| FR2818642B1 (fr) * | 2000-12-26 | 2005-07-15 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion |
-
1999
- 1999-05-21 FR FR9906456A patent/FR2793794B1/fr not_active Expired - Fee Related
-
2000
- 2000-05-09 TW TW089108817A patent/TWI284130B/zh not_active IP Right Cessation
- 2000-05-18 PL PL00352293A patent/PL352293A1/xx not_active Application Discontinuation
- 2000-05-18 DZ DZ003166A patent/DZ3166A1/xx active
- 2000-05-18 JP JP2000619799A patent/JP2003500407A/ja not_active Abandoned
- 2000-05-18 AT AT00929625T patent/ATE370951T1/de not_active IP Right Cessation
- 2000-05-18 NZ NZ515556A patent/NZ515556A/en unknown
- 2000-05-18 US US09/979,389 patent/US7122669B1/en not_active Expired - Fee Related
- 2000-05-18 DE DE60036102T patent/DE60036102T2/de not_active Expired - Fee Related
- 2000-05-18 TR TR2001/03349T patent/TR200103349T2/xx unknown
- 2000-05-18 PT PT00929625T patent/PT1183256E/pt unknown
- 2000-05-18 UA UA2001128864A patent/UA68441C2/uk unknown
- 2000-05-18 IL IL14644100A patent/IL146441A0/xx unknown
- 2000-05-18 HU HU0201649A patent/HUP0201649A3/hu unknown
- 2000-05-18 ES ES00929625T patent/ES2290033T3/es not_active Expired - Lifetime
- 2000-05-18 SK SK1672-2001A patent/SK16722001A3/sk unknown
- 2000-05-18 CA CA002374714A patent/CA2374714A1/fr not_active Abandoned
- 2000-05-18 BR BR0011282-8A patent/BR0011282A/pt not_active Application Discontinuation
- 2000-05-18 CN CNB008106509A patent/CN1298719C/zh not_active Expired - Fee Related
- 2000-05-18 AU AU47645/00A patent/AU4764500A/en not_active Abandoned
- 2000-05-18 CZ CZ20014163A patent/CZ20014163A3/cs unknown
- 2000-05-18 EA EA200101224A patent/EA005072B1/ru not_active IP Right Cessation
- 2000-05-18 AP APAP/P/2001/002355A patent/AP1477A/en active
- 2000-05-18 YU YU86601A patent/YU86601A/sh unknown
- 2000-05-18 MX MXPA01011834A patent/MXPA01011834A/es active IP Right Grant
- 2000-05-18 DK DK00929625T patent/DK1183256T3/da active
- 2000-05-18 WO PCT/FR2000/001335 patent/WO2000071543A1/fr not_active Ceased
- 2000-05-18 EP EP00929625A patent/EP1183256B1/fr not_active Expired - Lifetime
- 2000-05-18 KR KR1020017014800A patent/KR100707895B1/ko not_active Expired - Fee Related
- 2000-05-19 AR ARP000102428A patent/AR035317A1/es not_active Application Discontinuation
-
2001
- 2001-11-15 MA MA26410A patent/MA26791A1/fr unknown
- 2001-11-20 NO NO20015659A patent/NO20015659L/no not_active Application Discontinuation
- 2001-11-21 ZA ZA200109602A patent/ZA200109602B/xx unknown
-
2004
- 2004-12-07 US US11/006,013 patent/US7208598B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006517955A (ja) * | 2003-02-18 | 2006-08-03 | アベンティス・ファーマ・ソシエテ・アノニム | 新規なプリン誘導体、それらの製造方法、医薬品としての適用、薬学的組成物、および新規な使用 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7122669B1 (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same | |
| US10533020B2 (en) | 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1 H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof | |
| CN110546151B (zh) | 凋亡诱导剂 | |
| US10226448B2 (en) | 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof | |
| JP2000513717A (ja) | カルボリン誘導体 | |
| JP2010533694A (ja) | Ｄｎａ−ｐｋ阻害剤 | |
| FR2820136A1 (fr) | Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation | |
| HUP0200535A2 (hu) | Ciklin-függő kináz-2 és IkB-alfagátló 2,6,9 triszubsztituált purinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| JP2022533740A (ja) | メチル基及びトリフルオロメチル基を含む二置換スルファミド系選択的ｂｃｌ－２阻害剤 | |
| WO2018015818A2 (en) | Therapeutic inhibitory compounds | |
| US10696677B2 (en) | Diaryl purine derivatives with improved bioavailability | |
| CN117285485B (zh) | 一种双磺酰胺类衍生物及其制备方法和应用 | |
| JP2005518384A (ja) | アデノシン受容体リガンドとして有用なトリアゾロ−キノリン誘導体 | |
| JP7471291B2 (ja) | 関節損傷を治療するための軟骨形成を誘導するための５－ヒドロキシ－７－オキサビシクロ［２．２．１］ヘプタン－２－カルボキサミド誘導体 | |
| JP4336299B2 (ja) | ５−リポキシゲナーゼ阻害活性を有する６−アルキルアミノ−２，２’−二重置換−７，８−二重置換−２ｈ−１−ベンゾピラン誘導体 | |
| AU2006202270A1 (en) | Purine derivatives, preparation method and pharmaceutical compositions containing same | |
| RU2782469C2 (ru) | Апоптоз-индуцирующие агенты | |
| CN101429164B (zh) | 左旋二苯甲基哌嗪衍生物及其制备方法 | |
| HK40093189A (en) | Apoptosis-inducing agents | |
| JPH06239862A (ja) | キサンチン誘導体 | |
| KR20230141050A (ko) | 피리미딘을 포함하는 폴리헤테로사이클 유도체 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070406 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070406 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070518 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20080812 |